ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Aurelio Chaux
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaux, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chaux, A.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2004;77:1505
© 2004 The Society of Thoracic Surgeons


Correspondence

Preservation of saphenous vein endothelium

Aurelio Chaux, MD

Cardiothoracic Surgery, Saint Johns Hospital and Health Center, 1328 Twenty-Second St, Santa Monica, CA 90404, USA

e-mail: drchaux{at}cs.com

To the Editor:

I read with a great deal of interest the article by Thatte and colleagues [1]; their work is well presented and, in my view, very valuable. I congratulate them for two important contributions to the study of the fate of veins used as arterial grafts: (1) the use of multiphoton microscopy and specific fluorescent stains for calcium and nitric oxide metabolism and (2) the introduction of the newly formulated storage solution GALA (glutathione, ascorbic acid, L-arginine).

In 1998, my colleagues and I [2] published an article on perivascular delivery of NO using a polymer and an NO donor (spermine/NO) applied around a vein graft implanted in the arterial circulation of hypercholesterolemic rabbits. These experiments demonstrated a significant reduction in neointimal hyperplasia in the treated vein grafts as compared with those bathed in saline solution or polymer alone. We noted in our study that the major limitation of this method of NO delivery in humans would be due to technical difficulties in controlling the application of the polymer + spermine/NO mixture and the inflammatory reaction that it produces in the surrounding tissues. We called for research in other methods of delivery of NO. I hope that further testing of the GALA solution using animal models such as the one we described will demonstrate the beneficial effects of this very simple and readily available modality of delivery and that surgeons soon will be able to use it for the benefit of their patients.

References

  1. Thatte H.S., Biswas K.S., Najjar S.F., et al. Multi-photon microscopic evaluation of saphenous vein endothelium and its preservation with a new solution, GALA. Ann Thorac Surg 2003;75:1145-1152.[Abstract/Free Full Text]
  2. Chaux A., Ruan X.M., Fishbein M.C., et al. Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation. J Thorac Cardiovasc Surg 1998;115:604-614.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Aurelio Chaux
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaux, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chaux, A.
Related Collections
Right arrow Coronary disease


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS